Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Telron
- Development stage
- Unknown
- Lead developer
- Hellix Healthcare
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Telron is a branded pharmaceutical formulation of telmisartan, an angiotensin II receptor blocker (ARB) manufactured by Hellix Healthcare. It is primarily indicated for the management of essential hypertension and heart failure, and is used to reduce the risk of cardiovascular morbidity and mortality in patients with manifest cardiovascular disease or type 2 diabetes mellitus with documented target organ damage. Telmisartan works by selectively blocking the binding of angiotensin II to the Type-1 angiotensin II receptor (AT1) in tissues such as vascular smooth muscle and the adrenal gland. This action results in vasodilation and a decrease in the secretion of aldosterone, thereby lowering blood pressure and reducing cardiovascular strain. Additionally, Telron is utilized to help preserve kidney function in patients with diabetes.
- Brand names
- TelronTelron 40Telron40Telron-40Telron 80Telron80Telron-80
- Other names
- telmisartan
02
Targets
AGTR1 (Angiotensin II Type-1 receptor)
Beyond the preview
Go deeper on Telron.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Telron.